美股市場個股詳情
JANX Janux Therapeutics
- 46.390
- -1.610-3.35%
收盤價 11/27 16:00 (美東)
- 44.080
- -2.310-4.98%
盤後 20:01 (美東)
24.35億總市值-39649市盈率TTM
49.690最高價46.300最低價65.01萬股成交量48.100今開48.000昨收3053.23萬成交額1.71%換手率虧損市盈率(靜)5248.20萬總股本65.60052周最高3.71市淨率17.63億流通值7.79052周最低--股息TTM3800.65萬流通股65.600歷史最高--股息率TTM7.06%振幅5.650歷史最低46.963平均價1股每手
Janux Therapeutics關鍵統計數據
季報+年報
顯示同比
| (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | -82.56%43.9萬 | 741.72%889.7萬 | -38.87%125.2萬 | -6.14%808.3萬 | -13.50%246.1萬 | 38.83%251.7萬 | -55.31%105.7萬 | 28.89%204.8萬 | 136.79%861.2萬 | 76.05%284.5萬 |
| 營業收入 | -82.56%43.9萬 | 741.72%889.7萬 | -38.87%125.2萬 | -6.14%808.3萬 | -13.50%246.1萬 | 38.83%251.7萬 | -55.31%105.7萬 | 28.89%204.8萬 | 136.79%861.2萬 | 76.05%284.5萬 |
| 主營業務成本 | ||||||||||
| 毛利 | ||||||||||
| 營業費用 | 97.93%3,628.1萬 | 4.19%2,271.9萬 | -4.10%2,141.3萬 | 7.08%8,106.2萬 | -11.90%1,859.8萬 | -7.59%1,833萬 | 11.10%2,180.5萬 | 47.57%2,232.9萬 | 107.03%7,570.3萬 | 39.75%2,111.1萬 |
| 銷售和管理費用 | 174.42%1,766.7萬 | 13.66%782.1萬 | 13.60%734.3萬 | 17.42%2,614萬 | 11.98%635.7萬 | 5.58%643.8萬 | 24.21%688.1萬 | 30.67%646.4萬 | 115.53%2,226.2萬 | 44.20%567.7萬 |
| -管理費用 | 174.42%1,766.7萬 | 13.66%782.1萬 | 13.60%734.3萬 | 17.42%2,614萬 | 11.98%635.7萬 | 5.58%643.8萬 | 24.21%688.1萬 | 30.67%646.4萬 | 115.53%2,226.2萬 | 44.20%567.7萬 |
| 研發費用 | 56.53%1,861.4萬 | -0.17%1,489.8萬 | -11.31%1,407萬 | 2.77%5,492.2萬 | -20.69%1,224.1萬 | -13.43%1,189.2萬 | 5.95%1,492.4萬 | 55.78%1,586.5萬 | 103.69%5,344.1萬 | 38.19%1,543.4萬 |
| 營業利潤 | -126.66%-3,584.2萬 | 33.38%-1,382.2萬 | 0.59%-2,016.1萬 | -8.78%-7,297.9萬 | 11.66%-1,613.7萬 | 12.26%-1,581.3萬 | -20.20%-2,074.8萬 | -49.76%-2,028.1萬 | -103.74%-6,709.1萬 | -35.40%-1,826.6萬 |
| 淨非營業利息收入（費用） | 83.35%778.3萬 | 142.69%786.3萬 | 91.39%540.1萬 | 264.24%1,468.6萬 | 98.96%437.9萬 | 220.14%424.5萬 | 768.63%324萬 | 2,037.88%282.2萬 | 1,468.87%403.2萬 | 2,874.32%220.1萬 |
| 利息收入 | 83.35%778.3萬 | 142.69%786.3萬 | 91.39%540.1萬 | 264.24%1,468.6萬 | 98.96%437.9萬 | 220.14%424.5萬 | 768.63%324萬 | 2,037.88%282.2萬 | 1,468.87%403.2萬 | 2,874.32%220.1萬 |
| 其他淨收入（費用） | ||||||||||
| 稅前利潤 | -142.56%-2,805.9萬 | 65.96%-595.9萬 | 15.46%-1,476萬 | 7.56%-5,829.3萬 | 26.81%-1,175.8萬 | 30.71%-1,156.8萬 | -3.67%-1,750.8萬 | -30.19%-1,745.9萬 | -93.01%-6,305.9萬 | -19.75%-1,606.5萬 |
| 所得稅 | ||||||||||
| 除稅後利潤 | -142.56%-2,805.9萬 | 65.96%-595.9萬 | 15.46%-1,476萬 | 7.56%-5,829.3萬 | 26.81%-1,175.8萬 | 30.71%-1,156.8萬 | -3.67%-1,750.8萬 | -30.19%-1,745.9萬 | -93.01%-6,305.9萬 | -19.75%-1,606.5萬 |
| 持續經營利潤 | -142.56%-2,805.9萬 | 65.96%-595.9萬 | 15.46%-1,476萬 | 7.56%-5,829.3萬 | 26.81%-1,175.8萬 | 30.71%-1,156.8萬 | -3.67%-1,750.8萬 | -30.19%-1,745.9萬 | -93.01%-6,305.9萬 | -19.75%-1,606.5萬 |
| 歸屬於少數股東的淨利潤 | ||||||||||
| 歸屬於母公司的淨利潤 | -142.56%-2,805.9萬 | 65.96%-595.9萬 | 15.46%-1,476萬 | 7.56%-5,829.3萬 | 26.81%-1,175.8萬 | 30.71%-1,156.8萬 | -3.67%-1,750.8萬 | -30.19%-1,745.9萬 | -93.01%-6,305.9萬 | -19.75%-1,606.5萬 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | ||||||||||
| 歸屬於普通股股東的淨利潤 | -142.56%-2,805.9萬 | 65.96%-595.9萬 | 15.46%-1,476萬 | 7.56%-5,829.3萬 | 26.81%-1,175.8萬 | 30.71%-1,156.8萬 | -3.67%-1,750.8萬 | -30.19%-1,745.9萬 | -93.01%-6,305.9萬 | -19.75%-1,606.5萬 |
| 基本每股收益 | -104.00%-0.51 | 73.81%-0.11 | 28.57%-0.3 | 13.16%-1.32 | 38.46%-0.24 | 37.50%-0.25 | -2.44%-0.42 | -31.25%-0.42 | -9.35%-1.52 | -18.18%-0.39 |
| 稀釋每股收益 | -104.00%-0.51 | 73.81%-0.11 | 28.57%-0.3 | 13.16%-1.32 | 38.46%-0.24 | 37.50%-0.25 | -2.44%-0.42 | -31.25%-0.42 | -9.35%-1.52 | -18.18%-0.39 |
| 每股派息 | ||||||||||
| 貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| 審計意見 | -- | -- | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- |
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據